FDA Approved: MYCAPSSA — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MYCAPSSA (oral octreotide) submitted by Chiesi USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• MYCAPSSA (OCTREOTIDE)

Snippet

SUPPL AP for MYCAPSSA (OCTREOTIDE)